{"id":6551,"date":"2024-11-27T15:54:02","date_gmt":"2024-11-27T15:54:02","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/?p=6551"},"modified":"2026-11-20T14:21:02","modified_gmt":"2026-11-20T14:21:02","slug":"in-vivo-cro-market-imarc","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/in-vivo-cro-market-imarc\/","title":{"rendered":"\uc720\ud615(\uc124\uce58\ub958, \ube44\uc124\uce58\ub958), GLP \uc720\ud615(\ube44GLP, GLP \ub3c5\uc131\ud559), \uc801\uc751\uc99d(\uc790\uac00\uba74\uc5ed\/\uc5fc\uc99d\uc131 \uc9c8\ud658, \ud1b5\uc99d \uad00\ub9ac, \uc885\uc591\ud559, CNS \uc9c8\ud658, \ub2f9\ub1e8\ubcd1, \ube44\ub9cc \ubc0f \uae30\ud0c0) \ubc0f \uc9c0\uc5ed\ubcc4 \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \ubcf4\uace0\uc11c 2026-2034"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/11\/62130deb-841e-494b-99ae-98c76fff4b83slide_1.webp\" alt=\"Market Report Image\" style=\"max-width:100%;\"><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/11\/f0274656-94ca-455c-a3b8-019e562a0106slide_2.webp\" alt=\"Market Report Image\" style=\"max-width:100%;\"><\/p>\n<p>1 \uc11c\ubb38<br \/>\n2 \ubc94\uc704 \ubc0f \ubc29\ubc95\ub860<br \/>\n    2.1 \uc5f0\uad6c \ubaa9\ud45c<br \/>\n    2.2 \uc774\ud574\uad00\uacc4\uc790<br \/>\n    2.3 \ub370\uc774\ud130 \ucd9c\ucc98<br \/>\n        2.3.1 1\ucc28 \ucd9c\ucc98<br \/>\n        2.3.2 2\ucc28 \ucd9c\ucc98<br \/>\n    2.4 \uc2dc\uc7a5 \ucd94\uc815<br \/>\n        2.4.1 \uc0c1\ud5a5\uc2dd \uc811\uadfc \ubc29\uc2dd<br \/>\n        2.4.2 \ud558\ud5a5\uc2dd \uc811\uadfc \ubc29\uc2dd<br \/>\n    2.5 \uc608\uce21 \ubc29\ubc95\ub860<br \/>\n3 \uc694\uc57d<br \/>\n4 \uc11c\ub860<br \/>\n    4.1 \uac1c\uc694<br \/>\n    4.2 \uc8fc\uc694 \uc0b0\uc5c5 \ub3d9\ud5a5<br \/>\n5 \uae00\ub85c\ubc8c \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5<br \/>\n    5.1 \uc2dc\uc7a5 \uac1c\uc694<br \/>\n    5.2 \uc2dc\uc7a5 \uc131\uacfc<br \/>\n    5.3 COVID-19\uc758 \uc601\ud5a5<br \/>\n    5.4 \uc2dc\uc7a5 \uc608\uce21<br \/>\n6 \uc720\ud615\ubcc4 \uc2dc\uc7a5 \ubd84\ub958<br \/>\n    6.1 \uc124\uce58\ub958<br \/>\n        6.1.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n        6.1.2 \uc8fc\uc694 \ubd80\ubb38<br \/>\n            6.1.2.1 \uc950<br \/>\n            6.1.2.2 \uc0dd\uc950<br \/>\n            6.1.2.3 \uae30\ud0c0<br \/>\n        6.1.3 \uc2dc\uc7a5 \uc608\uce21<br \/>\n    6.2 \ube44\uc124\uce58\ub958<br \/>\n        6.2.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n        6.2.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n7 GLP \uc720\ud615\ubcc4 \uc2dc\uc7a5 \ubd84\ub958<br \/>\n    7.1 \ube44GLP<br \/>\n        7.1.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n        7.1.2 \uc8fc\uc694 \ubd80\ubb38<br \/>\n            7.1.2.1 \uc790\uccb4<br \/>\n            7.1.2.2 \uc544\uc6c3\uc18c\uc2f1<br \/>\n        7.1.3 \uc2dc\uc7a5 \uc608\uce21<br \/>\n    7.2 GLP \ub3c5\uc131\ud559<br \/>\n        7.2.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n        7.2.2 \uc8fc\uc694 \ubd80\ubb38<br \/>\n            7.2.2.1 \uc790\uccb4<br \/>\n            7.2.2.2 \uc544\uc6c3\uc18c\uc2f1<br \/>\n        7.2.3 \uc2dc\uc7a5 \uc608\uce21<br \/>\n8 \uc801\uc751\uc99d\ubcc4 \uc2dc\uc7a5 \ubd84\ub958<br \/>\n    8.1 \uc790\uac00\uba74\uc5ed\/\uc5fc\uc99d\uc131 \uc9c8\ud658<br \/>\n        8.1.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n        8.1.2 \uc8fc\uc694 \ubd80\ubb38<br \/>\n            8.1.2.1 \ub958\ub9c8\ud2f0\uc2a4 \uad00\uc808\uc5fc<br \/>\n            8.1.2.2 \ub2e4\ubc1c\uc131 \uacbd\ud654\uc99d<br \/>\n            8.1.2.3 \uace8\uad00\uc808\uc5fc<br \/>\n            8.1.2.4 \uacfc\ubbfc\uc131 \ub300\uc7a5 \uc99d\ud6c4\uad70<br \/>\n            8.1.2.5 \uae30\ud0c0<br \/>\n        8.1.3 \uc2dc\uc7a5 \uc608\uce21<br \/>\n    8.2 \ud1b5\uc99d \uad00\ub9ac<br \/>\n        8.2.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n        8.2.2 \uc8fc\uc694 \ubd80\ubb38<br \/>\n            8.2.2.1 \ub9cc\uc131 \ud1b5\uc99d<br \/>\n            8.2.2.2 \uae09\uc131 \ud1b5\uc99d<br \/>\n        8.2.3 \uc2dc\uc7a5 \uc608\uce21<br \/>\n    8.3 \uc885\uc591\ud559<br \/>\n        8.3.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n        8.3.2 \uc8fc\uc694 \ubd80\ubb38<br \/>\n            8.3.2.1 \ud608\uc561\uc554<br \/>\n            8.3.2.2 \uace0\ud615\uc554<br \/>\n            8.3.2.3 \uae30\ud0c0<br \/>\n        8.3.3 \uc2dc\uc7a5 \uc608\uce21<br \/>\n    8.4 \uc911\ucd94\uc2e0\uacbd\uacc4 \uc9c8\ud658<br \/>\n        8.4.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n        8.4.2 \uc8fc\uc694 \ubd80\ubb38<br \/>\n            8.4.2.1 \uac04\uc9c8<br \/>\n            8.4.2.2 \ud30c\ud0a8\uc2a8\ubcd1<br \/>\n            8.4.2.3 \ud5cc\ud305\ud134\ubcd1<br \/>\n            8.4.2.4 \ub1cc\uc878\uc911<br \/>\n            8.4.2.5 \uc678\uc0c1\uc131 \ub1cc \uc190\uc0c1<br \/>\n            8.4.2.6 ALS<br \/>\n            8.4.2.7 \uadfc\uc721 \uc7ac\uc0dd<br \/>\n            8.4.2.8 \uae30\ud0c0<br \/>\n        8.4.3 \uc2dc\uc7a5 \uc608\uce21<br \/>\n    8.5 \ub2f9\ub1e8\ubcd1<br \/>\n        8.5.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n        8.5.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n    8.6 \ube44\ub9cc<br \/>\n        8.6.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n        8.6.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n    8.7 \uae30\ud0c0<br \/>\n        8.7.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n        8.7.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n9 \uc9c0\uc5ed\ubcc4 \uc2dc\uc7a5 \ubd84\ub958<br \/>\n    9.1 \ubd81\ubbf8<br \/>\n        9.1.1 \ubbf8\uad6d<br \/>\n            9.1.1.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.1.1.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n        9.1.2 \uce90\ub098\ub2e4<br \/>\n            9.1.2.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.1.2.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n    9.2 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<br \/>\n        9.2.1 \uc911\uad6d<br \/>\n            9.2.1.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.2.1.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n        9.2.2 \uc77c\ubcf8<br \/>\n            9.2.2.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.2.2.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n        9.2.3 \uc778\ub3c4<br \/>\n            9.2.3.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.2.3.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n        9.2.4 \ub300\ud55c\ubbfc\uad6d<br \/>\n            9.2.4.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.2.4.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n        9.2.5 \ud638\uc8fc<br \/>\n            9.2.5.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.2.5.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n        9.2.6 \uc778\ub3c4\ub124\uc2dc\uc544<br \/>\n            9.2.6.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.2.6.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n        9.2.7 \uae30\ud0c0<br \/>\n            9.2.7.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.2.7.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n    9.3 \uc720\ub7fd<br \/>\n        9.3.1 \ub3c5\uc77c<br \/>\n            9.3.1.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.3.1.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n        9.3.2 \ud504\ub791\uc2a4<br \/>\n            9.3.2.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.3.2.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n        9.3.3 \uc601\uad6d<br \/>\n            9.3.3.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.3.3.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n        9.3.4 \uc774\ud0c8\ub9ac\uc544<br \/>\n            9.3.4.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n            9.3.4.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n        9.3.5 \uc2a4\ud398\uc778<br \/>\n            9.3.5.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n9.3.5.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n9.3.6 \ub7ec\uc2dc\uc544<br \/>\n9.3.6.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n9.3.6.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n9.3.7 \uae30\ud0c0<br \/>\n9.3.7.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n9.3.7.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n9.4 \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74<br \/>\n9.4.1 \ube0c\ub77c\uc9c8<br \/>\n9.4.1.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n9.4.1.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n9.4.2 \uba55\uc2dc\ucf54<br \/>\n9.4.2.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n9.4.2.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n9.4.3 \uae30\ud0c0<br \/>\n9.4.3.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n9.4.3.2 \uc2dc\uc7a5 \uc608\uce21<br \/>\n9.5 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<br \/>\n9.5.1 \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n9.5.2 \uad6d\uac00\ubcc4 \uc2dc\uc7a5 \uc138\ubd84\ud654<br \/>\n9.5.3 \uc2dc\uc7a5 \uc608\uce21<br \/>\n10 SWOT \ubd84\uc11d<br \/>\n10.1 \uac1c\uc694<br \/>\n10.2 \uac15\uc810<br \/>\n10.3 \uc57d\uc810<br \/>\n10.4 \uae30\ud68c<br \/>\n10.5 \uc704\ud611<br \/>\n11 \uac00\uce58 \uc0ac\uc2ac \ubd84\uc11d<br \/>\n12 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d<br \/>\n12.1 \uac1c\uc694<br \/>\n12.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<br \/>\n12.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<br \/>\n12.4 \uacbd\uc7c1 \uc815\ub3c4<br \/>\n12.5 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<br \/>\n12.6 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<br \/>\n13 \uac00\uaca9 \ubd84\uc11d<br \/>\n14 \uacbd\uc7c1 \ud658\uacbd<br \/>\n14.1 \uc2dc\uc7a5 \uad6c\uc870<br \/>\n14.2 \uc8fc\uc694 \uc5c5\uccb4<br \/>\n14.3 \uc8fc\uc694 \uc5c5\uccb4 \ud504\ub85c\ud544<br \/>\n14.3.1 \ubc14\uc774\uc624\uc0ac\uc774\ud1a0\uc820 (Biocytogen)<br \/>\n14.3.1.1 \ud68c\uc0ac \uac1c\uc694<br \/>\n14.3.1.2 \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624<br \/>\n14.3.1.3 \uc7ac\ubb34<br \/>\n14.3.1.4 SWOT \ubd84\uc11d<br \/>\n14.3.2 \ucc30\uc2a4 \ub9ac\ubc84 \ub798\ubc84\ub7ec\ud1a0\ub9ac\uc2a4 (Charles River Laboratories)<br \/>\n14.3.2.1 \ud68c\uc0ac \uac1c\uc694<br \/>\n14.3.2.2 \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624<br \/>\n14.3.2.3 \uc7ac\ubb34<br \/>\n14.3.2.4 SWOT \ubd84\uc11d<br \/>\n14.3.3 \ud06c\ub77c\uc6b4 \ubc14\uc774\uc624\uc0ac\uc774\uc5b8\uc2a4 (Crown Bioscience)<br \/>\n14.3.3.1 \ud68c\uc0ac \uac1c\uc694<br \/>\n14.3.3.2 \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624<br \/>\n14.3.3.3 \uc7ac\ubb34<br \/>\n14.3.3.4 SWOT \ubd84\uc11d<br \/>\n14.3.4 \uc720\ub85c\ud540\uc2a4 \ub514\uc2a4\ucee4\ubc84\ub9ac (Eurofins Discovery)<br \/>\n14.3.4.1 \ud68c\uc0ac \uac1c\uc694<br \/>\n14.3.4.2 \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624<br \/>\n14.3.4.3 \uc7ac\ubb34<br \/>\n14.3.4.4 SWOT \ubd84\uc11d<br \/>\n14.3.5 \uc5d0\ubcf4\ud14d (Evotec)<br \/>\n14.3.5.1 \ud68c\uc0ac \uac1c\uc694<br \/>\n14.3.5.2 \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624<br \/>\n14.3.5.3 \uc7ac\ubb34<br \/>\n14.3.5.4 SWOT \ubd84\uc11d<br \/>\n14.3.6 \ud3ec\ud2b8\ub9ac\uc544 (Fortrea)<br \/>\n14.3.6.1 \ud68c\uc0ac \uac1c\uc694<br \/>\n14.3.6.2 \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624<br \/>\n14.3.6.3 \uc7ac\ubb34<br \/>\n14.3.6.4 SWOT \ubd84\uc11d<br \/>\n14.3.7 \uc544\uc774\ucf58 \ud50c\uc528 (Icon Plc)<br \/>\n14.3.7.1 \ud68c\uc0ac \uac1c\uc694<br \/>\n14.3.7.2 \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624<br \/>\n14.3.7.3 \uc7ac\ubb34<br \/>\n14.3.7.4 SWOT \ubd84\uc11d<br \/>\n14.3.8 \uc544\uc774\ud050\ube44\uc544 (IQVIA Inc.)<br \/>\n14.3.8.1 \ud68c\uc0ac \uac1c\uc694<br \/>\n14.3.8.2 \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624<br \/>\n14.3.8.3 \uc7ac\ubb34<br \/>\n14.3.8.4 SWOT \ubd84\uc11d<br \/>\n14.3.9 \uc544\uc774\ub9ac\uc2a4 \ud30c\ub9c8 (Iris Pharma)<br \/>\n14.3.9.1 \ud68c\uc0ac \uac1c\uc694<br \/>\n14.3.9.2 \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624<br \/>\n14.3.10 \ud0c0\ucf54\ub2c9 \ubc14\uc774\uc624\uc0ac\uc774\uc5b8\uc2a4 (Taconic Biosciences, Inc.)<br \/>\n14.3.10.1 \ud68c\uc0ac \uac1c\uc694<br \/>\n14.3.10.2 \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624<br \/>\n14.3.10.3 \uc7ac\ubb34<br \/>\n14.3.10.4 SWOT \ubd84\uc11d<br \/>\n14.3.11 \uc6b0\uc2dc \uc571\ud14d (WuXi AppTec)<br \/>\n14.3.11.1 \ud68c\uc0ac \uac1c\uc694<br \/>\n14.3.11.2 \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624<br \/>\n14.3.11.3 \uc7ac\ubb34<br \/>\n\uadf8\ub9bc \ubaa9\ub85d<br \/>\n\uadf8\ub9bc 1: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \uc8fc\uc694 \ub3d9\uc778 \ubc0f \uacfc\uc81c<br \/>\n\uadf8\ub9bc 2: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\uc2ed\uc5b5 USD), 2020-2025<br \/>\n\uadf8\ub9bc 3: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\uc2ed\uc5b5 USD), 2026-2034<br \/>\n\uadf8\ub9bc 4: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \uc720\ud615\ubcc4 \uc138\ubd84\ud654 (%), 2025<br \/>\n\uadf8\ub9bc 5: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: GLP \uc720\ud615\ubcc4 \uc138\ubd84\ud654 (%), 2025<br \/>\n\uadf8\ub9bc 6: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \uc801\uc751\uc99d\ubcc4 \uc138\ubd84\ud654 (%), 2025<br \/>\n\uadf8\ub9bc 7: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \uc9c0\uc5ed\ubcc4 \uc138\ubd84\ud654 (%), 2025<br \/>\n\uadf8\ub9bc 8: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\uc124\uce58\ub958) \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 9: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\uc124\uce58\ub958) \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 10: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\ube44\uc124\uce58\ub958) \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 11: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\ube44\uc124\uce58\ub958) \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 12: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\ube44GLP) \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 13: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\ube44-GLP) \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 14: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (GLP \ub3c5\uc131\ud559) \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 15: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (GLP \ub3c5\uc131\ud559) \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 16: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\uc790\uac00\uba74\uc5ed\/\uc5fc\uc99d\uc131 \uc9c8\ud658) \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 17: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\uc790\uac00\uba74\uc5ed\/\uc5fc\uc99d\uc131 \uc9c8\ud658) \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 18: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\ud1b5\uc99d \uad00\ub9ac) \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 19: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\ud1b5\uc99d \uad00\ub9ac) \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 20: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\uc885\uc591\ud559) \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 21: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\uc885\uc591\ud559) \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 22: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\uc911\ucd94\uc2e0\uacbd\uacc4 \uc9c8\ud658) \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 23: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\uc911\ucd94\uc2e0\uacbd\uacc4 \uc9c8\ud658) \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 24: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\ub2f9\ub1e8\ubcd1) \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 25: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\ub2f9\ub1e8\ubcd1) \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 26: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\ube44\ub9cc) \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 27: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\ube44\ub9cc) \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 28: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\uae30\ud0c0 \uc801\uc751\uc99d) \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 29: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO (\uae30\ud0c0 \uc801\uc751\uc99d) \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 30: \ubd81\ubbf8: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 31: \ubd81\ubbf8: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 32: \ubbf8\uad6d: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 33: \ubbf8\uad6d: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 34: \uce90\ub098\ub2e4: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 35: \uce90\ub098\ub2e4: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 36: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 37: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 38: \uc911\uad6d: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 39: \uc911\uad6d: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 40: \uc77c\ubcf8: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 41: \uc77c\ubcf8: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 42: \uc778\ub3c4: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 43: \uc778\ub3c4: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 44: \ub300\ud55c\ubbfc\uad6d: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 45: \ub300\ud55c\ubbfc\uad6d: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 46: \ud638\uc8fc: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 47: \ud638\uc8fc: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 48: \uc778\ub3c4\ub124\uc2dc\uc544: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 49: \uc778\ub3c4\ub124\uc2dc\uc544: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 50: \uae30\ud0c0: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 51: \uae30\ud0c0: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 52: \uc720\ub7fd: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 53: \uc720\ub7fd: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 54: \ub3c5\uc77c: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 55: \ub3c5\uc77c: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 56: \ud504\ub791\uc2a4: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 57: \ud504\ub791\uc2a4: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 58: \uc601\uad6d: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 59: \uc601\uad6d: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 60: \uc774\ud0c8\ub9ac\uc544: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ud310\ub9e4 \uac00\uce58 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 61: \uc774\ud0c8\ub9ac\uc544: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 62: \uc2a4\ud398\uc778: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 63: \uc2a4\ud398\uc778: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 64: \ub7ec\uc2dc\uc544: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 65: \ub7ec\uc2dc\uc544: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 66: \uae30\ud0c0: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 67: \uae30\ud0c0: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 68: \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 69: \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 70: \ube0c\ub77c\uc9c8: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 71: \ube0c\ub77c\uc9c8: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 72: \uba55\uc2dc\ucf54: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 73: \uba55\uc2dc\ucf54: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 74: \uae30\ud0c0: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 75: \uae30\ud0c0: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 76: \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2020 &#038; 2025<br \/>\n\uadf8\ub9bc 77: \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5: \uad6d\uac00\ubcc4 \ubd84\ub958 (%), 2025<br \/>\n\uadf8\ub9bc 78: \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74: \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \uc608\uce21: \ub9e4\ucd9c\uc561 (\ubc31\ub9cc USD), 2026-2034<br \/>\n\uadf8\ub9bc 79: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO \uc0b0\uc5c5: SWOT \ubd84\uc11d<br \/>\n\uadf8\ub9bc 80: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO \uc0b0\uc5c5: \uac00\uce58 \uc0ac\uc2ac \ubd84\uc11d<br \/>\n\uadf8\ub9bc 81: \uae00\ub85c\ubc8c: \uc0dd\uccb4 \ub0b4 CRO \uc0b0\uc5c5: \ud3ec\ud130\uc758 5\uac00\uc9c0 \ud798 \ubd84\uc11d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uae00\ub85c\ubc8c \uc0dd\uccb4 \ub0b4(in-vivo) CRO \uc2dc\uc7a5\uc740 2025\ub144 57\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2034\ub144 101\uc5b5 \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, 2026\ub144\ubd80\ud130 2034\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 6.49%\uc758 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uc804\ub9dd\uc785\ub2c8\ub2e4. \ub9cc\uc131 \uc9c8\ud658\uc758 \ud655\uc0b0\uacfc \uc81c\uc57d \ud68c\uc0ac\uc758 R&#038;D \uc9c0\ucd9c \uc99d\uac00\ub294 \uc2dc\uc7a5 \uc131\uc7a5\uc758 \uc8fc\uc694 \ub3d9\ub825\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\uc778\uc73c\ub85c\ub294 \ubc14\uc774\uc624\ud14c\ud06c \uc2a4\ud0c0\ud2b8\uc5c5\uc758 \uae09\uc99d\uacfc \uac1c\uc778 \ub9de\ucda4\ud615 \uc815\ubc00 \uc758\ud559\uc5d0 \ub300\ud55c \uad00\uc2ec \uc99d\uac00\uac00 \uc788\uc2b5\ub2c8\ub2e4. \uc804\uc784\uc0c1 \uc5f0\uad6c \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00\uc640 \uc5f0\uad6c \ubc29\ubc95\ub860\uc5d0 \uc778\uacf5\uc9c0\ub2a5 \ub3c4\uc785 \ud655\ub300\ub294 \ud575\uc2ec \uc2dc\uc7a5 \ud2b8\ub80c\ub4dc\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uacbd\uc7c1 \ud658\uacbd\uc5d0\ub294 Biocytogen, Charles River Laboratories, Crown Bioscience, Eurofins Discovery, Evotec, Fortrea, Icon Plc, IQVIA Inc., Iris Pharma, Taconic Biosciences, Inc., WuXi AppTec \ub4f1\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4. \ubd81\ubbf8\ub294 \uc120\uc9c4 \uc758\ub8cc \uc778\ud504\ub77c, \uac15\ub825\ud55c \uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \ubd80\ubb38, \ub192\uc740 R&#038;D \ud22c\uc790\ub85c \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub192\uc740 \ube44\uc6a9\uacfc \uaddc\uc81c \ubb38\uc81c\ub294 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\uc9c0\ub9cc, \ucca8\ub2e8 \uae30\uc220 \ub3c4\uc785\uacfc \uaddc\uc81c \uc900\uc218 \ud504\ub85c\uc138\uc2a4 \uac04\uc18c\ud654\ub97c \ud1b5\ud55c \ud6a8\uc728\uc131 \ud5a5\uc0c1 \ubc0f \ube44\uc6a9 \uc808\uac10\uc740 \ud5a5\ud6c4 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc9c0\uc18d\uc801\uc73c\ub85c \uacac\uc778\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc81c\uc57d \ud68c\uc0ac\ub4e4\uc758 \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00\ub294 \uc5f0\uad6c \ud6a8\uc728\uc131\uc744 \ub192\uc774\uace0 \ube44\uc6a9\uc744 \uc808\uac10\ud558\uae30 \uc704\ud55c \uc804\ub7b5\uc73c\ub85c, CRO\ub294 \ub3d9\ubb3c \uc5f0\uad6c\uc5d0 \ub300\ud55c \uc804\ubb38 \uc9c0\uc2dd\uc744 \uc81c\uacf5\ud558\uc5ec \uc2e0\uc57d \uac1c\ubc1c \ubc0f \uaddc\uc81c \uc2b9\uc778\uc744 \uac00\uc18d\ud654\ud569\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, 2024\ub144 7\uc6d4 IntegriChain\uc740 Federal Compliance Solutions(FCS)\ub97c \uc778\uc218\ud558\uc5ec \uc218\uc775\uc131 \uc788\ub294 \uc758\uc57d\ud488 \uc0c1\uc5c5\ud654 \uc804\ub7b5 \uac1c\ubc1c\uc744 \ubaa9\ud45c\ub85c \ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc804\ubb38 CRO \uc11c\ube44\uc2a4\uc758 \ub4f1\uc7a5\uc740 \uc804\uc784\uc0c1 \uc5f0\uad6c\uc5d0\uc11c \ud2c8\uc0c8 \uc804\ubb38 \uc9c0\uc2dd\uc5d0 \ub300\ud55c \uc218\uc694 \uc99d\uac00\ub97c \ubc18\uc601\ud569\ub2c8\ub2e4. \uc774\ub4e4 CRO\ub294 \ub3d9\ubb3c \ubaa8\ub378\ub9c1, \uc57d\ub3d9\ud559, \ub3c5\uc131\ud559 \ub4f1 \ub9de\ucda4\ud615 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud558\uc5ec \uc2e0\uc57d \uac1c\ubc1c \ud6a8\uc728\uc131\uacfc \uc815\ubc00\ub3c4\ub97c \ub192\uc785\ub2c8\ub2e4. 2024\ub144 6\uc6d4 Lindus Health\ub294 \uc0dd\uccb4 \ub0b4 CRO \uc804\ubb38 \uc9c0\uc2dd\uacfc \ucca8\ub2e8 \uae30\uc220\uc744 \uacb0\ud569\ud55c \uc62c\uc778\uc6d0 \uc758\ub8cc\uae30\uae30 CRO \uc11c\ube44\uc2a4\ub97c \ucd9c\uc2dc\ud558\uc5ec \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uac04\uc18c\ud654\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2e0\uc57d \uac1c\ubc1c\uc5d0 \ub300\ud55c \uc9d1\uc911 \uc99d\uac00\ub294 \uc0dd\uccb4 \ub0b4 CRO\uc5d0 \ub300\ud55c \uc9c0\uc6d0 \ud655\ub300\ub85c \uc774\uc5b4\uc9d1\ub2c8\ub2e4. \uc774\ub4e4 \uc870\uc9c1\uc740 \uc804\uc784\uc0c1 \ud14c\uc2a4\ud2b8\uc5d0 \ud544\uc218\uc801\uc778 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud558\uc5ec \uc81c\uc57d \ud68c\uc0ac\uac00 \uc0b4\uc544\uc788\ub294 \uc720\uae30\uccb4\uc5d0\uc11c \uc2e0\uc57d\uc758 \uc548\uc804\uc131\uacfc \ud6a8\ub2a5\uc744 \ud3c9\uac00\ud558\uace0, \uac1c\ubc1c \ud504\ub85c\uc138\uc2a4\ub97c \uac00\uc18d\ud654\ud558\uba70 \ube44\uc6a9\uacfc \uc790\uc6d0 \uc694\uad6c \uc0ac\ud56d\uc744 \uc904\uc77c \uc218 \uc788\ub3c4\ub85d \ub3d5\uc2b5\ub2c8\ub2e4. 2024\ub144 5\uc6d4 Cannovation Clinical Research Partners\ub294 \ub300\ub9c8\ucd08 \uae30\ubc18 \uc758\uc57d\ud488 \uc784\uc0c1 \uc2dc\ud5d8 \uc804\ubb38 CRO\ub85c \ucd9c\ubc94\ud558\uc5ec \uc804\uc784\uc0c1 \ubc0f \uc784\uc0c1 \ub2e8\uacc4\ub97c \uc911\uc2ec\uc73c\ub85c \uce78\ub098\ube44\ub178\uc774\ub4dc \uae30\ubc18 \uce58\ub8cc\uc81c \uac1c\ubc1c\uc5d0 \uc8fc\ub825\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>IMARC Group\uc740 2026\ub144\ubd80\ud130 2034\ub144\uae4c\uc9c0 \uae00\ub85c\ubc8c, \uc9c0\uc5ed \ubc0f \uad6d\uac00 \uc218\uc900\uc5d0\uc11c \uae00\ub85c\ubc8c \uc0dd\uccb4 \ub0b4 CRO \uc2dc\uc7a5 \ubcf4\uace0\uc11c\uc758 \uac01 \ubd80\ubb38\ubcc4 \uc8fc\uc694 \ub3d9\ud5a5 \ubd84\uc11d\uacfc \uc608\uce21\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc0dd\uccb4 \ub0b4(in-vivo) CRO \uc2dc\uc7a5\uc740 \uc720\ud615, GLP \uc720\ud615, \uc801\uc751\uc99d, \uc9c0\uc5ed\ubcc4\ub85c \ubd84\uc11d\ub41c\ub2e4.<\/p>\n<p>**\uc720\ud615\ubcc4 \ubd84\uc11d:**<br \/>\n\uc124\uce58\ub958(\uc950, \uc0dd\uc950 \ub4f1)\uc640 \ube44\uc124\uce58\ub958\ub85c \ub098\ub258\uba70, \uc124\uce58\ub958\uac00 \uc2dc\uc7a5\uc758 \ub300\ubd80\ubd84\uc744 \ucc28\uc9c0\ud55c\ub2e4. \ud2b9\ud788 \uc0dd\uc950\uc640 \uc950\ub294 \uc778\uac04\uacfc\uc758 \uc720\uc804\uc801 \uc720\uc0ac\uc131, \ube44\uc6a9 \ud6a8\uc728\uc131, \ube60\ub978 \ubc88\uc2dd\ub825 \ub54c\ubb38\uc5d0 \uc554 \uc5f0\uad6c \ubc0f \uc57d\ubb3c \ud14c\uc2a4\ud2b8\uc640 \uac19\uc740 \uc804\uc784\uc0c1 \uc2dc\ud5d8\uc5d0 \uad11\ubc94\uc704\ud558\uac8c \uc0ac\uc6a9\ub41c\ub2e4. Envigo, Charles River Laboratories\uc640 \uac19\uc740 \uae30\uc5c5\ub4e4\uc740 \ucca8\ub2e8 \uc124\uce58\ub958 \ubaa8\ub378\uacfc \uc11c\ube44\uc2a4\ub97c \uac1c\ubc1c\ud558\uc5ec \uc57d\ubb3c \uac1c\ubc1c\uc758 \uc5ec\ub7ec \ub2e8\uacc4\ub97c \uc9c0\uc6d0\ud558\uace0 \uc788\ub2e4.<\/p>\n<p>**GLP \uc720\ud615\ubcc4 \ubd84\uc11d:**<br \/>\n\ube44GLP(\uc790\uccb4 \ubc0f \uc544\uc6c3\uc18c\uc2f1)\uc640 GLP \ub3c5\uc131\ud559(\uc790\uccb4 \ubc0f \uc544\uc6c3\uc18c\uc2f1)\uc73c\ub85c \uad6c\ubd84\ub418\uba70, GLP \ub3c5\uc131\ud559\uc774 \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud55c\ub2e4. \uc774\ub294 \uae30\uc5c5\ub4e4\uc774 \uc57d\ubb3c \uac1c\ubc1c\uc5d0\uc11c \uc5c4\uaca9\ud55c \uc548\uc804\uc131 \ud3c9\uac00\uc5d0 \ub300\ud55c \uc99d\uac00\ud558\ub294 \uc218\uc694\ub97c \ucda9\uc871\uc2dc\ud0a4\uae30 \uc704\ud574 \ub178\ub825\ud558\uae30 \ub54c\ubb38\uc774\ub2e4. Covance, Labcorp Drug Development\uc640 \uac19\uc740 \uc120\ub3c4\uc801\uc778 \uae30\uad00\ub4e4\uc740 \ud601\uc2e0\uc801\uc778 \uc5f0\uad6c \uc124\uacc4, \uc804\ubb38 \ub3c5\uc131\ud559 \ubaa8\ub378, \ud5a5\uc0c1\ub41c \ub370\uc774\ud130 \ubd84\uc11d \ud50c\ub7ab\ud3fc\uc744 \ud3ec\ud568\ud55c \uace0\uae09 GLP \ub3c5\uc131\ud559 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud558\uba70 \uc8fc\ubaa9\ubc1b\uace0 \uc788\ub2e4.<\/p>\n<p>**\uc801\uc751\uc99d\ubcc4 \ubd84\uc11d:**<br \/>\n\uc790\uac00\uba74\uc5ed\/\uc5fc\uc99d\uc131 \uc9c8\ud658(\ub958\ub9c8\ud2f0\uc2a4 \uad00\uc808\uc5fc, \ub2e4\ubc1c\uc131 \uacbd\ud654\uc99d \ub4f1), \ud1b5\uc99d \uad00\ub9ac(\ub9cc\uc131 \ud1b5\uc99d, \uae09\uc131 \ud1b5\uc99d), \uc885\uc591\ud559(\ud608\uc561\uc554, \uace0\ud615\uc554 \ub4f1), \uc911\ucd94\uc2e0\uacbd\uacc4(CNS) \uc9c8\ud658(\uac04\uc9c8, \ud30c\ud0a8\uc2a8\ubcd1 \ub4f1), \ub2f9\ub1e8\ubcd1, \ube44\ub9cc \ub4f1\uc73c\ub85c \ub098\ub258\uba70, \uc885\uc591\ud559\uc774 \uc2dc\uc7a5\uc5d0\uc11c \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud55c\ub2e4. \uc554 \uc57d\ubb3c \uc5f0\uad6c \ubc0f \uac1c\ubc1c\uc5d0 \ub300\ud55c \ub192\uc740 \uc218\uc694\uac00 \uc8fc\ub41c \uc774\uc720\uc774\ub2e4. CRO\ub4e4\uc740 \uc784\uc0c1 \uc2dc\ud5d8 \uc804\uc5d0 \uc0c8\ub85c\uc6b4 \uc885\uc591\ud559 \uce58\ub8cc\ubc95\uc758 \ud6a8\ub2a5\uacfc \uc548\uc804\uc131\uc744 \ud3c9\uac00\ud558\uae30 \uc704\ud574 \ub3d9\ubb3c \uc5f0\uad6c\ub97c \uc218\ud589\ud558\uba70, \uc0dd\uba85\uacf5\ud559 \ubc0f \uc81c\uc57d \ud68c\uc0ac\uc758 \uc2e0\uc57d \uac1c\ubc1c\uc744 \uc9c0\uc6d0\ud558\ub294 \ud601\uc2e0\uc774 \uc774 \ubd84\uc57c\uc758 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\ub2e4.<\/p>\n<p>**\uc9c0\uc5ed\ubcc4 \ubd84\uc11d:**<br \/>\n\ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4), \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591(\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud55c\uad6d, \ud638\uc8fc, \uc778\ub3c4\ub124\uc2dc\uc544 \ub4f1), \uc720\ub7fd(\ub3c5\uc77c, \ud504\ub791\uc2a4, \uc601\uad6d, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778, \ub7ec\uc2dc\uc544 \ub4f1), \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74(\ube0c\ub77c\uc9c8, \uba55\uc2dc\ucf54 \ub4f1), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74\ub85c \uad6c\uc131\ub41c\ub2e4. \uc774 \uc911 \ubd81\ubbf8\uac00 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud55c\ub2e4. \ubd81\ubbf8\ub294 \uc120\uc9c4 \uc758\ub8cc \uc778\ud504\ub77c, \uc0c1\ub2f9\ud55c R&#038;D \ud22c\uc790, \uc8fc\uc694 \uc81c\uc57d \ud68c\uc0ac\uc758 \uc874\uc7ac\ub85c \uc778\ud574 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud558\uace0 \uc788\ub2e4. \uc774 \uc9c0\uc5ed\uc740 \uac15\ub825\ud55c \uaddc\uc81c \ud504\ub808\uc784\uc6cc\ud06c, \uc219\ub828\ub41c \uc5f0\uad6c\uc6d0, \ub192\uc740 \uc784\uc0c1 \uc2dc\ud5d8 \ud65c\ub3d9\uc758 \uc774\uc810\uc744 \ub204\ub9ac\uace0 \uc788\ub2e4. \uc608\ub97c \ub4e4\uc5b4, \ubbf8\uad6d \ub0b4 \uc8fc\uc694 \uae30\uc5c5\uc778 Charles River Laboratories\ub294 \ud3ec\uad04\uc801\uc778 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud55c\ub2e4.<\/p>\n<p>\uc0dd\uccb4 \ub0b4(in-vivo) CRO(\uc784\uc0c1\uc2dc\ud5d8\uc218\ud0c1\uae30\uad00) \uc2dc\uc7a5\uc740 2025\ub144 100\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2034\ub144 250\uc5b5 \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, 2026\ub144\ubd80\ud130 2034\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 10.5%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774 \uc2dc\uc7a5\uc740 \uc2e0\uc57d \uac1c\ubc1c \uacfc\uc815\uc5d0\uc11c \uc0dd\uccb4 \ub0b4 \uc5f0\uad6c\uc758 \uc911\uc694\uc131\uc774 \ucee4\uc9c0\uace0, \uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5\ub4e4\uc774 \ube44\uc6a9 \ud6a8\uc728\uc131\uacfc \uc804\ubb38\uc131 \ud655\ubcf4\ub97c \uc704\ud574 CRO \uc11c\ube44\uc2a4\uc5d0 \ub300\ud55c \uc758\uc874\ub3c4\ub97c \ub192\uc774\uba74\uc11c \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \ub9cc\uc131 \uc9c8\ud658 \ubc0f \ud76c\uadc0 \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00, \uc2e0\uc57d \uac1c\ubc1c\uc744 \uc704\ud55c \uc5f0\uad6c \uac1c\ubc1c(R&#038;D) \ud22c\uc790 \ud655\ub300, \uadf8\ub9ac\uace0 CRO \uae30\uc5c5\ub4e4\uc774 \uc81c\uacf5\ud558\ub294 \uc804\ubb38\uc801\uc778 \uc11c\ube44\uc2a4\uc640 \uae30\uc220 \ubc1c\uc804\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788, CRO\ub294 \ubcf5\uc7a1\ud55c \uaddc\uc81c \ud658\uacbd\uc744 \ud0d0\uc0c9\ud558\uace0 \uc784\uc0c1\uc2dc\ud5d8\uc758 \ud6a8\uc728\uc131\uc744 \ub192\uc774\ub294 \ub370 \uc911\uc694\ud55c \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654\ub294 \ub2e4\uc591\ud55c \uae30\uc900\uc5d0 \ub530\ub77c \uc774\ub8e8\uc5b4\uc9d1\ub2c8\ub2e4.<br \/>\n* **\uc720\ud615\ubcc4:** \uc124\uce58\ub958(\uc950, \uc0dd\uc950 \ub4f1)\uc640 \ube44\uc124\uce58\ub958\ub85c \ub098\ub258\uba70, \uc124\uce58\ub958\uac00 \ube44\uc6a9 \ud6a8\uc728\uc131\uacfc \uc720\uc804\uc801 \uc870\uc791 \uc6a9\uc774\uc131\uc73c\ub85c \uc778\ud574 \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud569\ub2c8\ub2e4.<br \/>\n* **GLP \uc720\ud615\ubcc4:** \ube44GLP(\uc790\uccb4 \uc218\ud589, \uc544\uc6c3\uc18c\uc2f1)\uc640 GLP \ub3c5\uc131\ud559(\uc790\uccb4 \uc218\ud589, \uc544\uc6c3\uc18c\uc2f1)\uc73c\ub85c \uad6c\ubd84\ub429\ub2c8\ub2e4. GLP(Good Laboratory Practice)\ub294 \uc5f0\uad6c\uc758 \uc2e0\ub8b0\uc131\uacfc \ud488\uc9c8\uc744 \ubcf4\uc7a5\ud558\ub294 \ub370 \ud544\uc218\uc801\uc785\ub2c8\ub2e4.<br \/>\n* **\uc801\uc751\uc99d\ubcc4:** \uc790\uac00\uba74\uc5ed\/\uc5fc\uc99d\uc131 \uc9c8\ud658(\ub958\ub9c8\ud2f0\uc2a4 \uad00\uc808\uc5fc, \ub2e4\ubc1c\uc131 \uacbd\ud654\uc99d \ub4f1), \ud1b5\uc99d \uad00\ub9ac(\ub9cc\uc131\/\uae09\uc131 \ud1b5\uc99d), \uc885\uc591\ud559(\ud608\uc561\uc554, \uace0\ud615\uc554 \ub4f1), \uc911\ucd94\uc2e0\uacbd\uacc4(CNS) \uc9c8\ud658(\uac04\uc9c8, \ud30c\ud0a8\uc2a8\ubcd1 \ub4f1), \ub2f9\ub1e8\ubcd1, \ube44\ub9cc \ub4f1 \uad11\ubc94\uc704\ud55c \uc9c8\ud658 \uc601\uc5ed\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4.<br \/>\n* **\uc9c0\uc5ed\ubcc4:** \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74\ub85c \ub098\ub269\ub2c8\ub2e4. \ubd81\ubbf8\ub294 \uc120\uc9c4 \uc5f0\uad6c \uc778\ud504\ub77c\uc640 \ub192\uc740 R&#038;D \ud22c\uc790\ub85c \uc778\ud574 \ud604\uc7ac \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc2e0\ud765 \uacbd\uc81c\uad6d\uc758 R&#038;D \ud22c\uc790 \uc99d\uac00\uc640 \uc784\uc0c1\uc2dc\ud5d8 \ube44\uc6a9 \ud6a8\uc728\uc131\uc73c\ub85c \uc778\ud574 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc774 \ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub85c\ub294 Biocytogen, Charles River Laboratories, Crown Bioscience, Eurofins Discovery, Evotec, Fortrea, Icon Plc, IQVIA Inc., Iris Pharma, Taconic Biosciences, Inc., WuXi AppTec \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub4e4 \uae30\uc5c5\uc740 \ud601\uc2e0\uc801\uc778 \uae30\uc220\uacfc \uad11\ubc94\uc704\ud55c \uc11c\ube44\uc2a4 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c \ud1b5\ud574 \uc2dc\uc7a5 \uacbd\uc7c1\ub825\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ucd5c\uadfc \uc2dc\uc7a5 \ub3d9\ud5a5\uc744 \ubcf4\uba74, 2024\ub144 7\uc6d4 IntegriChain\uc740 Federal Compliance Solutions(FCS)\ub97c \uc778\uc218\ud558\uc5ec \uc758\uc57d\ud488 \uc0c1\uc5c5\ud654 \uc804\ub7b5\uc744 \uac15\ud654\ud588\uc2b5\ub2c8\ub2e4. 2024\ub144 6\uc6d4 Lindus Health\ub294 \uc758\ub8cc\uae30\uae30 CRO \uc11c\ube44\uc2a4\ub97c \ucd9c\uc2dc\ud558\uc5ec \uc784\uc0c1\uc2dc\ud5d8 \ud6a8\uc728\uc131\uc744 \ub192\uc600\uc2b5\ub2c8\ub2e4. 2024\ub144 5\uc6d4 Cannovation Clinical Research Partners\ub294 \ub300\ub9c8\ucd08 \uae30\ubc18 \uc758\uc57d\ud488 \uc784\uc0c1\uc2dc\ud5d8 \uc804\ubb38 CRO\ub85c \ucd9c\ubc94\ud558\uc5ec \uc0c8\ub85c\uc6b4 \uce58\ub8cc\uc81c \uac1c\ubc1c\uc5d0 \uc9d1\uc911\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 2020\ub144\ubd80\ud130 2034\ub144\uae4c\uc9c0\uc758 \uc2dc\uc7a5 \ub3d9\ud5a5, \uc608\uce21, \uc8fc\uc694 \ub3d9\uc778, \uacfc\uc81c \ubc0f \uae30\ud68c\ub97c \ud3ec\uad04\uc801\uc73c\ub85c \ubd84\uc11d\ud569\ub2c8\ub2e4. \ub610\ud55c \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1\uc694\uc18c \ubd84\uc11d\uc744 \ud1b5\ud574 \uc0b0\uc5c5\uc758 \uacbd\uc7c1 \uc218\uc900\uacfc \ub9e4\ub825\ub3c4\ub97c \ud3c9\uac00\ud558\uace0, \uc774\ud574\uad00\uacc4\uc790\ub4e4\uc774 \uc2dc\uc7a5 \ub0b4 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \uacbd\uc7c1 \ud658\uacbd\uc744 \uc774\ud574\ud558\ub294 \ub370 \ub3c4\uc6c0\uc744 \uc90d\ub2c8\ub2e4. \uc774\ub97c \ud1b5\ud574 \uc774\ud574\uad00\uacc4\uc790\ub4e4\uc740 \uc804\ub7b5\uc801 \uc758\uc0ac\uacb0\uc815\uc744 \ub0b4\ub9ac\uace0 \uc2dc\uc7a5\uc5d0\uc11c \uacbd\uc7c1 \uc6b0\uc704\ub97c \ud655\ubcf4\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-6551","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/6551"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=6551"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/6551\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=6551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=6551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=6551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}